Heparin Dosing for VTE Prophylaxis Based on Weight

Evidence-Based Dosing Recommendations

The American Society of Clinical Oncology recommends unfractionated heparin 5000 units subcutaneously every 8 hours for VTE prophylaxis in hospitalized patients with cancer or high-risk patients 1, 2, 4
Unfractionated heparin 5000 units subcutaneously every 12 hours has also been used but appears to be less effective, particularly in high-risk patients 2, 3
For patients weighing more than 100 kg, the American College of Chest Physicians recommends the more frequent dosing schedule of every 8 hours to ensure adequate prophylaxis 3
For patients weighing less than 100 kg without additional risk factors, the Mayo Clinic recommends the every 12 hour dosing regimen is generally sufficient 5

Patients weighing 100 kg or more should receive heparin 5000 units subcutaneously every 8 hours, as recommended by the American College of Chest Physicians 3
The more frequent dosing schedule helps maintain therapeutic levels due to the larger volume of distribution in patients weighing 100 kg or more 6

Patients with cancer may benefit from the more frequent every 8-hour dosing schedule regardless of weight due to their inherently higher VTE risk, as recommended by the National Comprehensive Cancer Network 1, 2, 7
Renal function does not significantly impact UFH dosing, making it preferable to LMWH in patients with severe renal impairment, according to the National Comprehensive Cancer Network 7
Monitoring of aPTT is not routinely required for prophylactic dosing of UFH, unlike with therapeutic dosing, as stated by the American College of Chest Physicians 8, 9

Using every 12-hour dosing in high-risk or obese patients may lead to subtherapeutic prophylaxis and increased VTE risk, as warned by the American Society of Clinical Oncology 1, 2
Failure to adjust dosing frequency based on weight may lead to either inadequate prophylaxis or increased bleeding complications, according to the American College of Chest Physicians 10, 6